Atticus Wealth Management, LLC
- SEC CIK
- 0001800234
- Latest filing
- Jul 15, 2026
AXSM holding history
Axsome Therapeutics, Inc. in every 13F filed by Atticus Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −15−100.0% | Sold out | Holders |
| Q2 2024 | 15 | $1.21K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 15 | $1.20K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 15 | $1.19K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 15 | $1.05K | <0.1% | −5−25.0% | Reduced | Holders |
| Q2 2023 | 20 | $1.44K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 20 | $1.23K | <0.1% | −1,000−98.0% | Reduced | Holders |
| Q4 2022 | 1,020 | $78.7K | <0.1% | −80−7.3% | Reduced | Holders |
| Q3 2022 | 1,100 | $42.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,100 | $42.0K | <0.1% | −100−8.3% | Reduced | Holders |
| Q1 2022 | 1,200 | $50.0K | <0.1% | +300+33.3% | Added | Holders |
| Q4 2021 | 900 | $34.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 900 | $30.0K | <0.1% | +900 | New | Holders |